The aim of this study was to determine the long-term prognostic value of infarct size and myocardial ischaemia on single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). 
Introduction
The prognostic value of single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is well defined in numerous patient subgroups with suspected or known stable coronary artery disease (CAD) as well as after ST-segment elevation myocardial infarction (STEMI), mainly in patients treated by thrombolysis. [1] [2] [3] [4] [5] [6] [7] In the contemporary era, thrombolysis has been replaced by primary percutaneous coronary intervention (PCI) as the preferred reperfusion strategy in patients presenting with STEMI. 8 A recent study showed a strong association between infarct size, measured by SPECT MPI within 1 month after STEMI and primary PCI, and short-term all-cause mortality and heart failure hospitalization. 9 Infarct size and the presence of myocardial ischaemia, assessed by SPECT MPI, may also be of significant value for the long-term risk stratification of STEMI patients treated with primary PCI. The use of these parameters may guide treatment strategy and thereby might lead to improved clinical outcome and a reduction in health care costs. To date, the long-term implications of SPECT MPI have not been evaluated in STEMI patients treated with primary PCI. Therefore, the purpose of this study was to determine the long-term prognostic value of SPECT infarct size and myocardial ischaemia after primary PCI for STEMI.
Methods
We retrospectively analysed patients with first STEMI who underwent primary PCI followed by SPECT MPI within 1-6 months (between 2004 and 2010). Patients who underwent coronary artery bypass grafting (CABG) during the index admission or a second revascularization procedure (PCI or CABG) after discharge and before SPECT MPI were excluded from this study. The primary outcome measures were the occurrence of cardiac death, reinfarction, and the composite of cardiac death or reinfarction. Clinical data were prospectively entered in the electronic patients file and retrospectively analysed.
SPECT MPI
Per institutional protocol, gated SPECT MPI was performed 3 months after primary PCI for STEMI. 10 Medication at discharge was continued before SPECT MPI. In all patients, a 2-day stress-rest protocol was performed. Patients underwent an exercise test (bicycle ergometry) or a pharmacological stress test with adenosine or dobutamine. Adenosine was administered during a 6-min period in a dose of 140 lg/kg/min. Dobutamine was administered during a 15-min period with increasing dose over time from 5 to 40 lg/kg/min and was supplemented with atropine if necessary. Depending on the stress method used, 99m
Tc tetrofosmin (500 MBq) was administered intravenously at the moment of peak stress (exercise test), 3 min after infusion of adenosine, or at a heart rate of at least 85% of the predicted maximum after dobutamine infusion.
SPECT MPI was performed 45 min after administration of tetrofosmin over a 360 orbit with a triple-head (GCA 9300/HG; Toshiba Corporation, Tokyo, Japan) or dual-head SPECT camera system (GCA 7200/HG; Toshiba Corporation, Tokyo, Japan), both equipped with lowenergy high-resolution collimators. A 20% window was used around the 140 keV energy peak of 99m Tc, and the data were stored in a 64 Â 64 matrix. Stress and rest SPECT data sets were post-processed and reconstructed in vertical and horizontal long-axes and short-axis views perpendicular to the heart axis. 11 The left ventricular ejection fraction (LVEF) at rest and during stress was determined using the gated SPECT data.
Prognostic value of SPECT infarct size and ischaemia for the total cohort First, the prognostic value of SPECT infarct size and myocardial ischaemia after primary PCI for STEMI was evaluated in the total study population. Also, the difference between LVEF at rest and during stress (DLVEF) was calculated to investigate the impact of LVEF response during stress on outcome. The 17-segment model was used to define the vascular territories. 12, 13 For every segment, the tracer uptake was scored using a 5-point scale (0 = normal tracer uptake; 1 = mild reduction; 2 = moderate reduction; 3 = severe reduction; 4 = absent tracer uptake). Hereafter, the summed rest score (SRS) and summed stress score (SSS) were calculated by summation of the scores of the different segments at rest and during stress, respectively. The summed difference score (SDS) was defined as the absolute difference between the SSS and SRS. SPECT infarct size and the presence of myocardial ischaemia were defined by the SRS and SDS, respectively. For analysis purposes, the patient cohort was divided into three even groups according to the SRS (Group 1: 0-5, Group 2: 6-16, and Group 3: > _17) and SDS (Group 1: 0, Group 2: 1-3, Group 3: > _4). Furthermore, patients were assigned to four combined SRS/SDS categories according to the presence of ischaemia (SDS <2 vs. > _2) and the infarct size on SPECT according to the median SRS (SRS <10 vs. > _10). 14 
Subgroup analysis according to LVEF
Second, the study population was divided into patients with preserved LV function (LVEF > 45%) vs. reduced LV function (LVEF < _ 45%) to investigate the prognostic implications of SPECT infarct size and myocardial ischaemia in these subgroups. For this purpose, the LVEF at rest from the gated SPECT data was used. Mean age was 59.6 ± 11.2 years, 75.1% was male and 85.7% of the patients had > _1 cardiovascular risk factor. The LAD was the culprit vessel in 45.1% of patients and 50.2% had angiographic multi-vessel CAD, of whom 52.7% underwent complete revascularization. In patients who underwent complete revascularization, a smaller amount of SPECT ischaemia was observed compared to patients with incomplete revascularization (P = 0.057). Concordance between the performed PCI (of the culprit lesion) and the vascular territory with the largest infarct size on SPECT was found in 77.3% of the patients. Median peak cardiac troponin T and CK levels were 3.82 lg/L (IQR 1.55-7.57) and 1494 IU/L (IQR 700-3037), respectively. Exercise, adenosine, and dobutamine were used as stress test before SPECT MPI in 75.3%, 24.2%, and 0.5% of the patients, respectively. Median SRS was 10 (IQR 4-21) and median SDS was 0 (IQR 0-4).
Statistical analysis

Prognostic value of SPECT infarct size and ischaemia for the total cohort
The cumulative proportion of patients that experienced a primary outcome measure after 8 years of follow-up for cardiac death, reinfarction, and the composite of cardiac death or reinfarction was 2.4% (21 events), 9.2% (80 events), and 10.9% (95 events), respectively. Of all the cardiac deaths, 11 (52%) were due to heart failure, 4 (19%) were due to myocardial infarction, 5 (24%) were due to ventricular arrhythmia, and 1 (5%) was due to an unknown cardiac cause. After 8 years of follow-up, the cause-specific cumulative incidence of cardiac death or reinfarction was 6.7%, 11.3%, and 13.3% for the SRS Groups 1-3 (v 2 = 5.5; P = 0.019) ( Figure 1 ) and 10.7%, 8.4%, and 11.9% for the SDS In multivariable analysis, SPECT infarct size was independently associated with cardiac death (HR per 10% increase in SRS 1.81; 95% CI 1.27-2.59; P < 0.001), reinfarction (HR 1.23; 95% CI 1.04-1.46; P = 0.016), and the composite of cardiac death or reinfarction (HR 1.33; 95% CI 1.12-1.58; P = 0.001) (Tables 3 and 4). Myocardial ischaemia determined on SPECT was not associated with cardiac death (HR per 5% increase in SDS 1.12; 95% CI 0.63-1.99; P = 0.70), 
Subgroup analysis according to LVEF
In patients with LVEF < _ 45%, SPECT infarct size was independently associated with cardiac death or reinfarction (HR 1.59; 95% CI 1.15-2.22; P = 0.006), whereas myocardial ischaemia was not (HR 0.84; 95% CI 0.40-1.74; P = 0.64) ( Table 5) . However, in patients with LVEF > 45%, SPECT ischaemia was independently associated with cardiac death or reinfarction (HR 1.28; 95% CI 1.00-1.63; P = 0.050), while infarct size was not (HR 1.18; 95% CI 0.94-1.47; P = 0.15). Patients with LVEF < _ 45% showed a significantly larger SPECT infarct size compared to patients with LVEF > 45% (P < 0.001). Furthermore, patients with LVEF < _ 45% showed a significantly smaller amount of SPECT ischaemia compared to patients with LVEF > 45% (P = 0.001).
Discussion
In this study, the long-term prognostic value of SPECT MPI was investigated in STEMI patients treated with primary PCI. SPECT Figure 1 Cause-specific cumulative incidence of cardiac death or reinfarction with increasing SPECT infarct size. After 8 years of follow-up, the cause-specific cumulative incidence of cardiac death or reinfarction was in 6.7%, 11.3%, and 13.3% for the SRS categories (Group 1: SRS 0-5, Group 2: SRS 6-16, and Group 3: SRS > _17). CD, cardiac death; MI, myocardial infarction; SPECT, single-photon emission computed tomography; SRS, summed rest score. Figure 2 Cause-specific cumulative incidence of cardiac death or reinfarction with increasing SPECT ischaemia. After 8 years of follow-up, the cause-specific cumulative incidence of cardiac death or reinfarction was 10.7%, 8.4%, and 11.9% for the SDS categories (Group 1: SDS 0, Group 2: SDS 1-3, and Group 3: SDS > _4). CD, cardiac death; MI, myocardial infarction; SDS, summed difference score; SPECT, single-photon emission computed tomography. infarct size, but not myocardial ischaemia on SPECT, was independently associated with cardiac death and/or reinfarction. Addition of SPECT infarct size to a model including the clinical variables provided significant incremental prognostic value for the prediction of cardiac death or reinfarction, whereas addition of myocardial ischaemia on SPECT did not add significantly. In patients with LVEF < _ 45%, SPECT infarct size was independently associated with cardiac death or reinfarction, whereas myocardial ischaemia was not. Conversely, in patients with LVEF > 45%, only SPECT ischaemia was independently associated with cardiac death or reinfarction.
Prognostic value of SPECT infarct size and ischaemia after STEMI
The majority of studies that investigated the prognostic value of SPECT MPI in STEMI patients were performed at the time when thrombolysis was the main reperfusion treatment. Burns et al. 6 assessed the prognostic value of SPECT infarct size, LVEF from radionuclide angiography, and end-systolic volume index to predict 6-month mortality in 1181 patients who underwent SPECT MPI and 1194 patients who underwent radionuclide angiography treated with thrombolysis. SPECT infarct size was significantly associated with 6-month mortality (OR 1.033; 95% CI 1.008-1.060; P = 0.011), but offered no additional predictive power when adjusted for LVEF (OR 1.009; 95% CI 0.968-1.037; P = 0.89). myocardial ischaemia on SPECT was independently associated with cardiac death, reinfarction, readmission for acute coronary syndrome or severe congestive heart failure (v 2 = 17.8; P < 0.001), whereas SPECT infarct size was not (v 2 = 0.0; P = 0.92).
More recently, Stone et al. 9 investigated the prognostic value of infarct size measured by SPECT MPI or cardiac magnetic resonance (CMR) in STEMI patients after primary PCI. Pooled data from 10 randomized controlled trials were used in which infarct size was measured within 1 month after STEMI in 1889 patients who were followed up for 1 year. The results demonstrated that infarct size was independently associated with all-cause mortality (HR 1.19; 95% CI 1.18-1.20; P < 0.001) and heart failure hospitalization (HR 1.20; 95% CI 1.19-1.21; P < 0.001), but not with reinfarction (HR 1.02; 95% CI 1.01-1.04; P = 0.55). The current study adds to these results by confirming the long-term prognostic value of infarct size on SPECT to predict clinical outcome. Furthermore, our study shows no prognostic value of myocardial ischaemia on SPECT as a predictor of cardiac death or reinfarction in STEMI patients treated with primary PCI. Since previous studies have shown that recovery of myocardial perfusion may still improve the first weeks after infarction, we excluded patients who underwent SPECT MPI the first month after STEMI. 15, 16 Incremental prognostic value of SPECT infarct size and ischaemia for the total cohort
The prognostic value of SPECT MPI has been confirmed in various patient subgroups with suspected or known stable CAD. [1] [2] [3] [4] To our knowledge, this is the first study determining the long-term prognostic implications of infarct size and myocardial ischaemia on SPECT in STEMI patients treated with primary PCI. In the present study, SPECT infarct size added significant incremental value for the prediction of cardiac death or reinfarction beyond clinical variables, while myocardial ischaemia did not. An important explanation for this finding may be the low incidence of severe inducible ischaemia in our patient population. The majority of patients showed no or minimal inducible ischaemia on SPECT MPI, and only 10% of all patients showed severe inducible ischaemia (defined as > _10% of the left ventricle showing ischaemia or a SDS > _8). The low incidence of extensive inducible ischaemia could be a consequence of the high rate of complete revascularization in patients with multi-vessel CAD (53%). Moreover, it could be caused by the protective effect of cardiac medication in the cohort of STEMI patients, as 95% and 98% of the patients used beta-blockers and either angiotensin-converting enzyme (ACE) inhibitors or angiotensin-II-receptor blockers (ARB), respectively. This medication use is in accordance with the European Society of Cardiology (ESC) guidelines recommending the use of beta-blockers and ACE inhibitors in all STEMI patients without contraindications. 8 Therefore, we believe that the observed low incidence of severe inducible ischaemia may not be unique to our study population, but could also be representative for other STEMI patients treated with modern extensive medication according to the guidelines. Similar results were reported by Hachamovitch et al. 17, 18 who evaluated the relationship between the extent of myocardial ischaemia assessed by SPECT MPI and short-term survival in a large observational cohort with no prior CAD. Specifically, it was reported that overall cardiac death rate was only 0.7% in patients without inducible ischaemia who were treated medically. SPECT, single-photon emission computed tomography.
Subgroup analysis according to LVEF
Interestingly, the prognostic value of SPECT infarct size and myocardial ischaemia after primary PCI for STEMI was different among patients with LVEF < _45% vs. >45%. Infarct size on SPECT was independently associated with the occurrence of cardiac death or reinfarction in patients with LVEF < _ 45%, but not in patients with LVEF >45%. Because patients with LVEF < _ 45% showed a significantly larger infarct size on SPECT compared to patients with LVEF > 45%, this may largely explain the association between infarct size and outcome in patients with LVEF < _ 45%. Conversely, myocardial ischaemia on SPECT was independently associated with cardiac death or reinfarction in patients with LVEF > 45%, but not in patients with LVEF < _ 45%. Since patients with LVEF > 45% demonstrated a significantly larger amount of ischaemia on SPECT compared to patients with LVEF < _ 45%, this may explain these observations. The combined effect of LVEF and SPECT ischaemia on outcome was also studied by Sharir et al. 14 in 2686 patients who underwent SPECT MPI with a mean follow-up time of 21 months. Of these patients, 26% and 19% had a history of myocardial infarction and PCI, respectively. In patients with a history of myocardial infarction, median time between myocardial infarction and SPECT MPI was 3.9 years, and only 73 patients underwent SPECT MPI within 3 months of the myocardial infarction. In accordance with our study, the authors noted that myocardial ischaemia improved risk stratification in patients with normal or mildly to moderately reduced LVEF, but not in patients with severely reduced LVEF.
Limitations
First, our study is a retrospective study with all its inherent limitations. Second, only a small percentage of our study population of STEMI patients showed severe inducible ischaemia on SPECT MPI, but this is related to the current therapy (use of PCI vs. thrombolysis, complete vs. incomplete revascularization) and more intensified medication use after infarction. Third, some patients underwent revascularization (either PCI or CABG) during follow-up which may have prevented cardiac events, although we adjusted for the effects of revascularization. 19 Fourth, although no patients were included who underwent SPECT MPI within 1 month after STEMI and primary PCI, we cannot exclude ongoing remodelling in patients 1 month after infarction.
Conclusion
In this study, the long-term prognostic value of SPECT MPI was investigated in STEMI patients treated with primary PCI. SPECT infarct size, but not myocardial ischaemia on SPECT, was independently associated with cardiac death and/or reinfarction. Infarct size on SPECT added significant incremental value to predict cardiac death or reinfarction beyond clinical parameters. Myocardial ischaemia did not add further incremental information in STEMI patients undergoing primary PCI and treated with optimized medical therapy during follow-up. In patients with LVEF < _ 45%, SPECT infarct size was independently associated with cardiac death or reinfarction, whereas myocardial ischaemia was not. Conversely, in patients with LVEF > 45%, only SPECT ischaemia was independently associated with cardiac death or reinfarction.
